Author: <span>Asbestos / Mesothelioma News From Medical News Today</span>

Penn Medicine: Immunotherapy drug pembrolizumab shows promise for mesothelioma patients

PD-1 inhibitor is safe, shrank tumors or stabilized disease in most patientsThe PD-1 inhibitor pembrolizumab, a cancer immunotherapy drug, shrank or halted growth of tumors in 76 percent of…

Penn Medicine: Immunotherapy drug pembrolizumab shows promise for mesothelioma patients

PD-1 inhibitor is safe, shrank tumors or stabilized disease in most patientsThe PD-1 inhibitor pembrolizumab, a cancer immunotherapy drug, shrank or halted growth of tumors in 76 percent of…

Investigational personalized cellular therapy tolerated well by patients

Promising results of Phase I trial show successful migration of immune cells to tumor sitesGenetically modified versions of patients’ own immune cells successfully traveled to tumors they were…

Mesothelioma in southern Nevada likely result of asbestos in environment

Malignant mesothelioma has been found at higher than expected levels in women and in individuals younger than 55 years old in the southern Nevada counties of Clark and Nye, likewise in the same…

A high number of genomic mutations in advanced malignant plural mesothelioma revealed by targeted next-generation sequencing

Next generation sequencing in malignant pleural mesothelioma (MPM) tumors shows a complex mutational setting with a high number of genetic alterations in genes involved in DNA repair, cell survival…

A high number of genomic mutations in advanced malignant plural mesothelioma identified by targeted next-generation sequencing

Next generation sequencing in malignant pleural mesothelioma (MPM) tumors shows a complex mutational setting with a high number of genetic alterations in genes involved in DNA repair, cell survival…

Studies report new findings on treatment options for mesothelioma

Treating patients with high-dose radiotherapy after chemotherapy and surgery for malignant pleural mesothelioma does not achieve improvements in local relapse and overall survival, according to…

Thoracic radiation therapy can lead to modest acute changes in cardiac biomarkers and electrocardiogram findings

There were only modest acute changes in cardiac biomarkers and electrocardiograms and there were no clinically significant cardiac events in patients with high-dose radiation exposure to the heart…

Curcumin, special peptides boost cancer-blocking PIAS3 to neutralize cancer-activating STAT3 in mesothelioma

A common Asian spice and cancer-hampering molecules show promise in slowing the progression of mesothelioma, a cancer of the lung’s lining often linked to asbestos.

Biomarkers accurately distinguish mesothelioma from non-cancerous tissue

Scientists have identified four biomarkers that may help resolve the difficult differential diagnosis between malignant pleural mesothelioma (MPM) and non-cancerous pleural tissue with reactive…